Studies have reported that ANGPT1 gene-modified human MSCs could promote angiogenesis and reduce acute pancreatitis in rats [91], while PDGFRA+ MSCs have enhanced skin repair/regeneration potential [92]. The gene discussed is ANGPT1; the disease is acute pancreatitis.